All 1 tracked stories fall under one category: earnings. Bentley Systems is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 6 original sources per story, versus 3.4 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Heron Therapeutics
All 1 tracked stories fall under one category: earnings. Bentley Systems is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 6 original sources per story, versus 3.4 across the same-window beat baseline. At 5, the average consequence score sits below the same-window beat average of 5.9. Heron Therapeutics appears in 1 tracked SaaS story from February 25, 2026.
Stories tracked
1
Sources per story
6
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 27 SaaS stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Heron Therapeutics. Shared-story counts are live from our verified record — not editorial picks.
A wave of Q4 2025 earnings previews highlights the growing intersection of specialized SaaS platforms and high-stakes medical and infrastructure sectors. Companies like Delcath Systems and Bentley Systems are under scrutiny as investors look for evidence of commercial scaling and software-driven efficiency gains.